drug development
AI-Designed Drug Offers Hope for Inflammatory Bowel Disease Treatment
NeelRatan
Insilico Medicine has announced positive results from Phase I trials of ISM5411, an AI-designed drug aimed at treating inflammatory bowel disease. The studies conducted in Australia and China show promise for this innovative treatment, reflecting advancements in generative AI for drug development.
Schrödinger CEO Discusses Physics-Driven AI for Drug Discovery
NeelRatan
Schrödinger's CEO discusses the company's innovative approach to using physics in AI-driven drug discovery. By integrating advanced computational methods, they aim to enhance the efficiency and effectiveness of developing new medications, potentially transforming the pharmaceutical industry.
